Jason Lippert, President and CEO, has engaged in significant trading activity across two companies—LCII and NX—with a clear but narrowing bias toward accumulation. Over 29 reported transactions, Lippert has purchased $13.9 million worth of shares while selling $7.3 million, reflecting a net buying trend. However, recent filings show a shift toward divestment, with three sales in February 2026 totaling $7.3 million in LCII stock, including a $4.4 million transaction on February 23 and a $1.4 million sale on February 24. These disposals contrast with earlier activity, where Lippert consistently acquired LCII shares through derivative transactions, such as $1.1 million, $1.0 million, and $1.0 million in March 2026.
Lippert’s involvement with NX has been minimal, limited to small acquisitions under $24,000 in 2025 and early 2026, with no recent activity. The bulk of his trading centers on LCII, where his sales in early 2026 mark a departure from prior years’ accumulation. The absence of recent buys suggests a potential change in strategy, though the sales could also represent routine portfolio management. The transactions, particularly the concentrated selling in LCII, warrant attention given their scale and timing, though the filings provide no context beyond the disclosed dollar amounts and execution dates.
AI-assisted summary